As shown in Figure 4a, we found that the EEF1A2 amount (ng/μL of sample) did not significantly discriminate between cases and controls, although there was a slight increase in the amount in BC patients compared to healthy controls (median 0.0367125 vs. 0.0297000, p = 0.053). Here, EEF1A2 is linked to breast cancer.